DeepKinase
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $15M
Investors
- 3
About DeepKinase
Based in Zhuhai, China and founded in 2019, DeepKinase operates as a precision medicine technology that focuses on developing clinical proteomics technologies. The company has set up branch offices in Beijing, Shanghai, Kunshan and Ontario. The founder as well as the CEO of the company, Naizhong Zheng, is also the co-founder of Mega Genomics. The CSO, Shuncheng Li, is a tenured professor in the Department of Biochemistry at the University of Western Ontario. The company's main product is its self-developed DeepKinase deep fully phosphorylated kinase proteomic platform, DoTK. The platform consists of three main sample processing technology platforms, a method package and mass spectrometry platform, and a database and bioinformatics AI platform. It also developed DoTD, DoTF, DoTB and other service platforms. DeepKinase has also launched a complete range of universal kits for the enrichment of the phosphorylated tyrosine kinase TyrosineKinase. The products and technologies can be used in tumor detection and drug development areas.
Who invested in DeepKinase
3 investors across 1 round
See all investors in DeepKinase
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 29, 2023
Amount
$15M
Investors
Questions about DeepKinase
Who invested in DeepKinase?
DeepKinase has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DeepKinase raised?
DeepKinase has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did DeepKinase last raise money?
DeepKinase's most recent round on record is a Series A, in Mar 2023.
What does DeepKinase do?
Based in Zhuhai, China and founded in 2019, DeepKinase operates as a precision medicine technology that focuses on developing clinical proteomics technologies.
Where is DeepKinase headquartered?
DeepKinase is headquartered in Zhuhai, China.
Which VCs invest in companies like DeepKinase?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at DeepKinase's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like DeepKinase? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.